AU2001232271A1 - Preventives/remedies for postoperative stress - Google Patents

Preventives/remedies for postoperative stress

Info

Publication number
AU2001232271A1
AU2001232271A1 AU2001232271A AU3227101A AU2001232271A1 AU 2001232271 A1 AU2001232271 A1 AU 2001232271A1 AU 2001232271 A AU2001232271 A AU 2001232271A AU 3227101 A AU3227101 A AU 3227101A AU 2001232271 A1 AU2001232271 A1 AU 2001232271A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
postoperative stress
postoperative
stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232271A
Inventor
Atsushi Hamada
Kazuhito Harada
Akira Miyazaki
Motohide Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of AU2001232271A1 publication Critical patent/AU2001232271A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001232271A 2000-02-14 2001-02-13 Preventives/remedies for postoperative stress Abandoned AU2001232271A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000/35963 2000-02-14
JP2000035963 2000-02-14
PCT/JP2001/000990 WO2001058489A1 (en) 2000-02-14 2001-02-13 Preventives/remedies for postoperative stress

Publications (1)

Publication Number Publication Date
AU2001232271A1 true AU2001232271A1 (en) 2001-08-20

Family

ID=18560078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232271A Abandoned AU2001232271A1 (en) 2000-02-14 2001-02-13 Preventives/remedies for postoperative stress

Country Status (5)

Country Link
EP (1) EP1293213A1 (en)
KR (1) KR20030016222A (en)
AU (1) AU2001232271A1 (en)
CA (1) CA2398956A1 (en)
WO (1) WO2001058489A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
TW201102390A (en) 2009-03-31 2011-01-16 Arqule Inc Substituted pyrazolo-pyrimidine compounds
EP2493889B1 (en) 2009-10-30 2017-09-06 Janssen Pharmaceutica, N.V. IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
PT2516434E (en) 2009-12-23 2015-10-05 Takeda Pharmaceutical Fused heteroaromatic pyrrolidinones as syk inhibitors
WO2011082267A2 (en) 2009-12-30 2011-07-07 Arqule, Inc. Substituted triazolo-pyrazine compounds
AR080754A1 (en) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv IMIDAZO DERIVATIVES (1,2-A) PIRAZINA AND ITS USE AS PDE10 INHIBITORS
US9056873B2 (en) 2011-06-22 2015-06-16 Takeda Pharmaceutical Company Limited Substituted 6-aza-isoindolin-1-one derivatives
AU2012277912B2 (en) 2011-06-27 2017-03-23 Janssen Pharmaceutica Nv 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
EP2863909B1 (en) 2012-06-26 2020-11-04 Janssen Pharmaceutica N.V. Combinations comprising 4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline compounds as pde 2 inhibitors and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
MX362197B (en) 2012-07-09 2019-01-08 Janssen Pharmaceutica Nv Inhibitors of phosphodiesterase 10 enzyme.
KR102220260B1 (en) * 2015-02-18 2021-02-25 버크 인스티튜트 포 리서치 온 에이징 Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0674641T3 (en) * 1992-12-17 1999-09-27 Pfizer Pyrrolopyrimidines as CRF antagonists
TW370529B (en) * 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
TW336932B (en) * 1992-12-17 1998-07-21 Pfizer Amino-substituted pyrazoles
KR0170567B1 (en) * 1992-12-17 1999-02-18 알렌 제이. 스피겔 Pyrazoles and pyrazolopyrimidines having crf antagonist activity
EP0959074A3 (en) * 1992-12-17 2000-06-07 Pfizer Inc. Substituted pyrazoles as CRF antagonists
WO1995010506A1 (en) * 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
FR2714059B1 (en) * 1993-12-21 1996-03-08 Sanofi Elf Branched amino derivatives of thiazole, processes for their preparation and pharmaceutical compositions containing them.
CN1149870A (en) * 1994-06-06 1997-05-14 辉瑞大药厂 Substituted pyrazoles having corticotropin-releasing factor (CRF) antagonist activity
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US5646152A (en) * 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
PL181895B1 (en) * 1994-06-16 2001-10-31 Pfizer Pyrazole and pyrrole pyridines
EP0729758A3 (en) * 1995-03-02 1997-10-29 Pfizer Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
DE69628804T2 (en) * 1995-12-08 2003-12-18 Pfizer Inc., New York Substituted heterocyclic derivatives as CRF antagonists
NZ330119A (en) * 1996-02-07 2000-02-28 Janssen Pharmaceutica Nv Pyrazolopyrimidines as crf receptor antagonists
US6107300A (en) * 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
US6022978A (en) * 1996-06-11 2000-02-08 Pfizer Inc. Benzimidazole derivatives
HU229024B1 (en) * 1996-07-24 2013-07-29 Bristol Myers Squibb Pharma Co Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
BR9710808A (en) * 1996-08-06 1999-08-17 Pfizer Bicyclic derivatives 6,6 or 6,7 containing substituted pyrite or pyrimido
TW477787B (en) * 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
CN1227554A (en) * 1996-08-28 1999-09-01 辉瑞大药厂 Substituted 6,5-hetero-bicyclic derivatives
AU6279598A (en) * 1997-02-18 1998-09-08 Neurocrine Biosciences, Inc. Biazacyclic CRF antagonists
DE69817172T2 (en) * 1997-03-26 2004-04-08 Taisho Pharmaceutical Co., Ltd. 4-tetrahydropyridylpyrimidine DERIVATIVES
BR9810508A (en) * 1997-07-03 2000-09-05 Du Pont Pharm Co Compound, pharmaceutical composition and method of treating a disorder
WO2000027846A2 (en) * 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
PT1129096E (en) * 1998-11-12 2003-09-30 Neurocrine Biosciences Inc CRF RECEPTOR ANTAGONISTS AND METHODS OF TREATMENT RELATED TO THEM

Also Published As

Publication number Publication date
WO2001058489A1 (en) 2001-08-16
EP1293213A1 (en) 2003-03-19
KR20030016222A (en) 2003-02-26
CA2398956A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001272759A1 (en) Preventives or remedies for atopic dermatitis
AU2001234128A1 (en) Novel imidazoline compounds
AU2001241095A1 (en) Preventives and/or remedies for hyperphosphatemia
AUPQ875700A0 (en) Combination compositions
EP1151704A3 (en) Delivery box
AU2002210925A1 (en) Preventives/remedies for portal hypertension
AU2001232271A1 (en) Preventives/remedies for postoperative stress
AU2002224596A1 (en) Preventives or remedies for obesity or fatty liver
AU2002222676A1 (en) Preventives or remedies for endometriosis
AU3987800A (en) Preventives/remedies for angiostenosis
AU2001220281A1 (en) Rollerboard for road-skiing
AU2002241326A1 (en) Remedies for psychoneurosis
AU2001240557A1 (en) Implant for cranioplastics
AU2002224133A1 (en) Remedies for dermatophytosis
AU2003236039A1 (en) Preventives/remedies for hotflash
AU2001274601A1 (en) Preventives or remedies for heart failure
AU2001295952A1 (en) Novel remedies or preventives for angiostenosis
AU2001235764A1 (en) Compositions
AU2001252578A1 (en) Preventives for influenza
AU2001232258A1 (en) Remedies for degenerative arthritis
AU2001264286A1 (en) Preventives/remedies for granuloma
AU2001282250A1 (en) Polyisocyanate composition
AU2002240841A1 (en) Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units